UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000028185
Receipt No. R000032258
Official scientific title of the study Screening of lacrimal duct obstruction using fluorescein dye dissapearing test by orthoptist
Date of disclosure of the study information 2017/07/11
Last modified on 2017/07/11 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Screening of lacrimal duct obstruction using fluorescein dye dissapearing test by orthoptist
Title of the study (Brief title) Screening of lacrimal duct obstruction by orthoptist
Region
Japan

Condition
Condition lacrimal duct obstruction
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate usability of Screening of lacrimal duct obstruction using fluorescein dye dissapearing test by orthoptist
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes sensitivity and specificity
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Application of fluorescein to conjunctiva
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria outpatients of our clinic
Key exclusion criteria patients who rejected this research
Target sample size 100

Research contact person
Name of lead principal investigator Hitoshi Imamura
Organization Tsukazaki Hospital
Division name Department of Ophthalmology
Address 68-1, Waku, Aboshi-ku, Himeji-city
TEL 079-272-8555
Email h.imamura@tsukazaki-eye.net

Public contact
Name of contact person Hitoshi Imamura
Organization Tsukazaki Hospital
Division name Department of Ophthalmology
Address 68-1, Waku, Aboshi-ku, Himeji-city
TEL 079-272-8555
Homepage URL
Email h.imamura@tsukazaki-eye.net

Sponsor
Institute Tsukazaki Hotspital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 07 Month 11 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 07 Month 11 Day
Anticipated trial start date
2017 Year 07 Month 11 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 07 Month 11 Day
Last modified on
2017 Year 07 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032258